The Harlow site was acquired in December 2016 from GlaxoSmithKline and provides an opportunity create c. 525,000 sq ft of Logistics Space alongside an existing 61,000 sq ft GSK facility leased back to Mulberry.  Mulberry obtained full outline and part detailed consent for Connex Park whilst securing the sites first pre-let before selling the site on in August 2018.

Development Details
Description Storage, Distribution and Data Centre Development Space with retained investment property
Site Area 44.6 Acres (27 acres developable)
Building Sizes 525,000 sq ft
Agent  JLL / M1
Status Complete